Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Erich

27 indexed publications match this author name.

ORCID: 0000-0002-7311-4426
OpenAlex: https://openalex.org/A5045362944

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 14 Brain Imaging 11 Emotional Processing 10 Aging 9 Mechanism of Action 8 Chronic Pain 5 Randomized Controlled Trial 5 Depression 5 Anxiety 5 Consciousness 4 Healthy Volunteers 4 Default Mode Network 3

Journals

Biological Psychiatry 4 European Neuropsychopharmacology 4 Universität Zürich, ZORA 2 Psychopharmacology 2 PLoS ONE 2 iScience 1 Scientific Reports 1 Molecular Psychiatry 1

Publication history

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatUniversität Zürich, ZORA · 2025-09-28 The pharmacological treatment of anxiety in people with eating disorders: A systematic review.Unknown journal · 2025-05-13 595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08 Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31 The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18 Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25 Novel treatments for anorexia nervosa: Insights from neuroplasticity research.Unknown journal · 2023-10-11 Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31 Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and MeditationBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2023-07-16 Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist’s Training?Cambridge Quarterly of Healthcare Ethics · 2023-03-01 Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27 Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12 P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low dosesEuropean Neuropsychopharmacology · 2019-11-30 Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24 LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07 Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30 Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17 The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21 Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31 P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24 Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25 Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15 The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26 Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09 Prediction of psilocybin response in healthy volunteers.PLoS ONE · 2012-02-16 Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.Journal of Psychopharmacology · 2010-09-19 Psychometric evaluation of the altered states of consciousness rating scale (OAV).PLoS ONE · 2010-08-30

Author directory